#08040: MCF7-F cells
Breast cancer cell line with acquired resistance to the anti-estrogen therapeutic fulvestrant (Faslodex)
………………………………………………………………………………………………………………
TECH FIELD(S)
Research material – cell line
………………………………………………………………………………………………………………
FEATURES
MCF7-F is a drug-resistant subline from a single colony of hormone-dependent breast cancer MCF7 cells. This cell line enables experimentation into the molecular characteristics of antiestrogen-resistant breast cancer in a uniform, clonal background.
………………………………………………………………………………………………………………
BENEFITS
- Extremely hard line to establish (approximately a year)
- Drug-resistance line to a clinically important therapeutic
- Uniform clonal background
………………………………………………………………………………………………………………
RESEARCHER (S)
Ken Nephew – Indiana University, Medical Sciences
………………………………………………………………………………………………………………
INTELLECTUAL PROPERTY STATUS
Available for material licensing
………………………………………………………………………………………………………………
CONTACT INFORMATION
For additional information on this technology, please contact Doug Bodde, Business Development Manager, IURTC:
Indiana University Research & Technology Corporation
351 West 10th Street
Indianapolis, IN 46202
Telephone: 812.855.1608
dbodde@iu.edu
………………………………………………………………………………………………………………
Still have a question? Ask here!